The Supernova brain stent has recently received approval from the Central Drugs Standard Control Organisation (CDSCO), marking a major step forward for stroke care in India. What makes this achievement special is that it’s the first time a stroke treatment device has been approved entirely on the basis of an Indian clinical trial. It’s also a proud moment for the country’s Make in India movement, showcasing the growing strength of homegrown medical innovation.
MBH/PS
Informative👍
A proud moment indeed! This is a significant step forward for Indian medical innovation.
Very Informative. Thanks for sharing!
The Supernova stent has been approved in India as a new treatment option for patients suffering from serious brain strokes caused by blood clots. This device helps doctors remove the clot from the brain’s blood vessels and restore normal blood flow, which can reduce brain damage and improve recovery. It has been developed in India and tested successfully in Indian hospitals, proving that it is safe and effective. Because it is made locally, the Supernova stent is expected to be more affordable, making advanced stroke treatment accessible to more patients across the country.
This is a landmark moment for Indian healthcare and medical innovation. Approval of the Supernova brain stent based solely on Indian clinical trial data not only strengthens confidence in our research ecosystem but also marks a major step toward self-reliance in advanced stroke care.